These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 29873030)
1. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid. Timirci-Kahraman O; Karaaslan Z; Tuzun E; Kurtuncu M; Baykal AT; Gunduz T; Tuzuner MB; Akgun E; Gurel B; Eraksoy M; Kucukali CI Acta Neurol Belg; 2019 Mar; 119(1):101-111. PubMed ID: 29873030 [TBL] [Abstract][Full Text] [Related]
2. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis. Tamam Y; Gunes B; Akbayir E; Kizilay T; Karaaslan Z; Koral G; Duzel B; Kucukali CI; Gunduz T; Kurtuncu M; Yilmaz V; Tuzun E; Turkoglu R Mult Scler Relat Disord; 2021 Feb; 48():102697. PubMed ID: 33352356 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome. Thouvenot E; Hinsinger G; Demattei C; Uygunoglu U; Castelnovo G; Pittion-Vouyovitch S; Okuda D; Kantarci O; Pelletier D; Lehmann S; Marin P; Siva A; Lebrun C Mult Scler; 2019 Apr; 25(5):669-677. PubMed ID: 29564952 [TBL] [Abstract][Full Text] [Related]
4. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis. Hinsinger G; Galéotti N; Nabholz N; Urbach S; Rigau V; Demattei C; Lehmann S; Camu W; Labauge P; Castelnovo G; Brassat D; Loussouarn D; Salou M; Laplaud D; Casez O; Bockaert J; Marin P; Thouvenot E Mult Scler; 2015 Sep; 21(10):1251-61. PubMed ID: 25698171 [TBL] [Abstract][Full Text] [Related]
5. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience. De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Comabella M; Fernández M; Martin R; Rivera-Vallvé S; Borrás E; Chiva C; Julià E; Rovira A; Cantó E; Alvarez-Cermeño JC; Villar LM; Tintoré M; Montalban X Brain; 2010 Apr; 133(Pt 4):1082-93. PubMed ID: 20237129 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis. Sellebjerg F; Royen L; Soelberg Sørensen P; Oturai AB; Jensen PEH Mult Scler; 2019 Oct; 25(11):1444-1451. PubMed ID: 30113249 [TBL] [Abstract][Full Text] [Related]
9. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases. Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412 [TBL] [Abstract][Full Text] [Related]
10. Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis. Cantó E; Tintoré M; Villar LM; Borrás E; Alvarez-Cermeño JC; Chiva C; Sabidó E; Rovira A; Montalban X; Comabella M J Neuroinflammation; 2014 Nov; 11():181. PubMed ID: 25406498 [TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis. Klíčová K; Mareš J; Sobek O; Rous Z; Rous M; Raška M; Hartung HP Eur J Neurosci; 2024 Jun; 59(11):2955-2966. PubMed ID: 38453679 [TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics. Shi Y; Ding Y; Li G; Wang L; Osman RA; Sun J; Qian L; Zheng G; Zhang G Front Immunol; 2021; 12():700031. PubMed ID: 34489947 [TBL] [Abstract][Full Text] [Related]
20. Oxylipins in cerebrospinal fluid in clinically isolated syndrome and relapsing remitting multiple sclerosis. Håkansson I; Gouveia-Figueira S; Ernerudh J; Vrethem M; Ghafouri N; Ghafouri B; Nording M Prostaglandins Other Lipid Mediat; 2018 Sep; 138():41-47. PubMed ID: 30118859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]